Contract 75A50120C00198
Mapp Biopharmaceutical, Inc. · Department Of Health And Human Services · September 28, 2020
Mapp Biopharmaceutical, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2020 for $5.04 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Diego, CA. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 11, 2026. If all options are exercised, the contract could reach $16.41 million.
Contract details
- PIID
- 75A50120C00198
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Drugs And Biologicals
- Place of performance
- San Diego, CA
- First action
- September 28, 2020
- Latest action
- March 11, 2026
Description
EOI: PRESIDENTIAL COST SAVINGS INITIATIVE (FEBRUARY 26, 2025): EOI NOTICE OF TERMINATION FOR CONVENIENCE
Modification timeline
-
March 11, 2026Mod P00013 · Other Administrative Action$16.41M
-
February 13, 2026Mod P00012 · Terminate For Convenience (Complete Or Partial)$16.41M
-
August 20, 2024Mod P00010 · Other Administrative ActionTHE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE ARTICLE G.7 INDIRECT COST RATE BASED ON DOCUMENTATION FROM NIH DATED AUGUST 2, 2024.$16.41M
-
June 24, 2024Mod P00009 · Other Administrative ActionTHE PURPOSE OF THIS IS TO UPDATE ARTICLES B.2, B.3, F.2(A) AND ARTICLE G.1, G.5, EXTEND POP FOR CLIN 0001, CLIN 0004, CLIN 0005, AND PROVIDE SUPPLEMENTAL FUNDING UNDER CLIN0001.$16.41M
-
September 9, 2021Mod P00001 · Supplemental Agreement For Work Within ScopeDEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE$16.30M
-
September 28, 2020Base awardDEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE$16.30M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00198?
Contract 75A50120C00198 is a federal contract awarded to Mapp Biopharmaceutical, Inc. by Department Of Health And Human Services on September 28, 2020 for $5.04 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75A50120C00198?
Mapp Biopharmaceutical, Inc. won contract 75A50120C00198 from Department Of Health And Human Services.
How much is contract 75A50120C00198 worth?
Contract 75A50120C00198 has obligated $5.04 million to date, with a total potential value of $16.41 million if all options are exercised.